HER2 heterodimerization with other HER members leads to the most potent of receptor combinations for causing continual downstream PI3K/Akt, Ras/MAPK, and JAK/STAT signaling, which drives oncogenic transformation and breast tumor growth. The gene discussed is SOAT1; the disease is breast neoplasm.